​

Funding Round

Series C - Genkyotex

Series C - Genkyotex

Investment Firm

Overview

Genkyotex develops innovative drugs to block the NOX enzymes that produce oxygen radicals.

Announced Date

May 24, 2011

Funding Type

Series C

Highlights

Location

Switzerland, Europe

Social

Investor Lead

Andera Partners

Andera Partners

Andera Partners is a early_stage_venture and late_stage_venture firm.

Participant Investors

5

Investor Name
Participant InvestorFondation d'Aide aux Entreprises
Participant InvestorEclosion SA
Participant InvestorVesalius Biocapital Partners
Participant InvestorMP Healthcare Venture Management
Participant InvestorAndera Partners

Round Details and Background

Genkyotex raised $20400000 on 2011-05-24 in Series C

Genkyotex develops innovative drugs to block the NOX enzymes that produce oxygen radicals.

Company Funding History

8

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 09, 2012
Series C - Genkyotex
4-25.6M
May 24, 2011
Series C - Genkyotex
5-20.4M
Jan 30, 2006
Seed Round - Genkyotex
1-1.6M
May 05, 2008
Series A - Genkyotex
1-4.0M

Recent Activity

There is no recent news or activity for this profile.